Tysabri May be Back on the Market

This is great news for Elan and Biogen/IDEC. Their stocks were blasted by the news that this was going to be taken off of the market. The drug may be a good hope for MS patients but let's hope the FDA really checks it out well. If it is pulled a 2nd time then everyone will have some explaining to do.